Key Facts The Hypotensive Escalation Metric : Within six months of initiating GLP-1 therapy, the rate of documented low blood pressure events among patients on multi-drug hypertension regimens jumped from 8.7% to 10.2%
Important safety considerations include risk of pancreatitis (treatment should be discontinued if suspected), gallbladder disease, and potential worsening of diabetic retinopathy in patients with pre-existing retinopathy who experience rapid improvement in glucose control (particularly with semaglutide)
Contact us today or schedule an appointment to learn more about Mounjaro and our comprehensive weight loss programs
These medications include semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and tirzepatide (Mounjaro, Zepbound)though tirzepatide is technically a dual GIP/GLP-1 receptor agonist, not a GLP-1 RA
40 Defective IRK activity is also implicated by decreased IRS1 tyrosine phosphorylation which is consistently observed in insulin-resistant skeletal muscles